EPISODE · May 6, 2026 · 1 MIN
Novo Nordisk's Wegovy Pill Skyrockets, Boosts Sales
from The Daily News Now! Business
Novo Nordisks Q1 numbers soar with Wegovy pill, generating $353 million, double analysts expectations. Overall sales up 24%, adjusted sales and profit down slightly, but beat estimates. Wegovy maintains double-digit growth despite Lillys oral competitor. Novo partners with OpenAI for AI in drug discovery, setting up a competitive landscape in obesity meds. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6b00fcfd6f9cb4cf
NOW PLAYING
Novo Nordisk's Wegovy Pill Skyrockets, Boosts Sales
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m